Dr Lal Pathlabs Ltd.
| BSE: 539524 | Sector: Health care |
| NSE: LALPATHLAB | ISIN Code: INE600L01024 |
| BSE 00:00 | 28 Jun | 2172.60 |
67.50 (3.21%) |
OPEN
2101.00 |
HIGH
2181.40 |
LOW
2061.00 |
| NSE 00:00 | 28 Jun | 2170.55 |
61.95 (2.94%) |
OPEN
2107.55 |
HIGH
2185.00 |
LOW
2060.00 |
| OPEN | 2101.00 |
| PREVIOUS CLOSE | 2105.10 |
| VOLUME | 9985 |
| 52-Week high | 4243.00 |
| 52-Week low | 1805.10 |
| P/E | 52.67 |
| Mkt Cap.(Rs cr) | 18,109 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Dr Lal Pathlabs Ltd. (LALPATHLAB) - Competition
| COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
| Sun Pharma.Inds. | 827.95 | 198,650.04 | 12,803.21 | 2,139.70 | 32,510.54 |
| Divi's Lab. | 3,613.95 | 95,932.30 | 6,798.61 | 1,954.72 | 9,297.17 |
| Cipla | 944.70 | 76,227.85 | 13,900.58 | 2,468.28 | 20,166.89 |
| Dr Reddy's Labs | 4,374.65 | 72,811.68 | 13,349.10 | 2,186.40 | 18,266.10 |
| Apollo Hospitals | 3,838.70 | 55,192.83 | 9,153.00 | 105.00 | 8,226.00 |
| Torrent Pharma. | 2,882.15 | 48,771.74 | 6,450.83 | 1,137.85 | 10,618.60 |
| Gland Pharma | 2,647.65 | 43,606.79 | 3,462.88 | 997.01 | 5,909.86 |
| Piramal Enterp. | 1,687.70 | 40,276.96 | 1,824.70 | 39.90 | 29,983.67 |
| Abbott India | 18,126.10 | 38,517.96 | 4,310.02 | 690.69 | 2,844.49 |
| Biocon | 316.20 | 37,962.97 | 2,028.40 | 280.50 | 8,024.20 |
| Zydus Lifesci. | 357.75 | 36,622.87 | 7,790.40 | 1,476.20 | 16,841.70 |
| Max Healthcare | 370.70 | 35,944.18 | 1,079.68 | -164.45 | 6,439.88 |
| Alkem Lab | 2,990.30 | 35,749.04 | 7,219.68 | 1,685.08 | 9,195.63 |
| Aurobindo Pharma | 521.30 | 30,542.97 | 15,823.68 | 3,112.91 | 19,952.13 |
| Lupin | 633.55 | 28,798.02 | 11,055.93 | 1,258.62 | 19,354.36 |
| Glaxosmi. Pharma | 1,498.55 | 25,386.94 | 3,193.74 | 357.57 | 1,798.50 |
| Laurus Labs | 468.70 | 25,185.59 | 4,707.04 | 750.09 | 5,178.13 |
| Ipca Labs. | 902.20 | 22,888.81 | 5,139.16 | 1,140.77 | 5,028.39 |
| Syngene Intl. | 567.80 | 22,793.19 | 2,179.40 | 403.70 | 4,022.40 |
| Pfizer | 4,098.30 | 18,749.72 | 2,238.55 | 497.61 | 2,494.06 |
Quick Links for Dr Lal Pathlabs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
